We are live on ! Find out more
ACM

Alethea Capital Management Portfolio holdings

AUM $241M
1-Year Est. Return 112.74%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+112.74%
3 Year Est. Return
+274.73%
5 Year Est. Return
+347.03%
10 Year Est. Return
+2,691.05%
AUM
$93.5M
AUM Growth
-$1.2M
Cap. Flow
-$5.31M
Cap. Flow %
-5.68%
Top 10 Hldgs %
81.33%
Holding
72
New
14
Increased
7
Reduced
14
Closed
21

Top Buys

Rank Stock Value
1
EXC icon
Exelon
EXC
+$620K
2
AIG icon
American International
AIG
+$602K
3
VTR icon
Ventas
VTR
+$591K
4
PFE icon
Pfizer
PFE
+$578K
5
NSC icon
Norfolk Southern
NSC
+$566K

Top Sells

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$1.9M
2
PEP icon
PepsiCo
PEP
+$740K
3
FAST icon
Fastenal
FAST
+$735K
4
F icon
Ford
F
+$699K
5
PSA icon
Public Storage
PSA
+$695K

Sector Composition

Rank Sector Weight
1 Healthcare 78.01%
2 Miscellaneous 4.02%
3 Financials 3.85%
4 Consumer Staples 3.05%
5 Industrials 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
1
Axsome Therapeutics
AXSM
$10.9B
$54.6M 58.4%
759,944
-25,739
-3% -$1.9M
RNAM
2
DELISTED
Avidity Biosciences
RNAM
$9.42M 10.08%
849,651
– –
KURA icon
3
Kura Oncology
KURA
$1.14B
$3.53M 3.77%
333,445
-30,328
-8% -$359K
TLT icon
4
iShares 20+ Year Treasury Bond ETF
TLT
$47.2B
$2.4M 2.56%
23,278
-922
-4% -$95.6K
CDTX
5
DELISTED
Cidara Therapeutics
CDTX
$1.84M 1.97%
81,384
-2,476
-3% -$58.2K
MRK icon
6
Merck
MRK
$366B
$959K 1.03%
8,312
+4,312
+108% +$490K
BIL icon
7
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.5B
$918K 0.98%
10,000
-1,000
-9% -$91.6K
DOW icon
8
Dow Inc
DOW
$21.5B
$831K 0.89%
15,607
+10,307
+194% +$548K
DUK icon
9
Duke Energy
DUK
$94.1B
$795K 0.85%
8,856
+5,856
+195% +$553K
CVS icon
10
CVS Health
CVS
$122B
$754K 0.81%
10,904
+684
+7% +$48.7K
PFE icon
11
Pfizer
PFE
$159B
$746K 0.8%
20,349
+14,849
+270% +$578K
SPPI
12
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$720K 0.77%
750,465
-37,508
-5% -$37.1K
AIG icon
13
American International
AIG
$39.4B
$646K 0.69%
+11,219
New +$602K
VTR icon
14
Ventas
VTR
$46.5B
$616K 0.66%
+13,035
New +$591K
EXC icon
15
Exelon
EXC
$45.2B
$611K 0.65%
+14,988
New +$620K
NSC icon
16
Norfolk Southern
NSC
$73.9B
$605K 0.65%
+2,666
New +$566K
BBY icon
17
Best Buy
BBY
$18.6B
$592K 0.63%
+7,219
New +$539K
HRL icon
18
Hormel Foods
HRL
$11.7B
$570K 0.61%
14,170
+9
+0.1% +$361
OKE icon
19
Oneok
OKE
$61.1B
$549K 0.59%
+8,893
New +$550K
KHC icon
20
Kraft Heinz
KHC
$29.3B
$519K 0.55%
+14,612
New +$562K
DOC icon
21
Healthpeak Properties
DOC
$14.2B
$517K 0.55%
+25,722
New +$534K
ARE icon
22
Alexandria Real Estate Equities
ARE
$8.81B
$511K 0.55%
+4,501
New +$536K
ZION icon
23
Zions Bancorporation
ZION
$10B
$507K 0.54%
+18,880
New +$524K
CFG icon
24
Citizens Financial Group
CFG
$29.7B
$485K 0.52%
+18,606
New +$513K
AAPL icon
25
Apple
AAPL
$4.62T
$456K 0.49%
2,351
– –
1
2 3

Similar funds

NIA
NIA Impact Advisors Berkeley, California $241M AUM 44.09% 1-Year Est. Return
PPW
PACK Private Wealth Wayzata, Minnesota $241M AUM 24.47% 1-Year Est. Return
CWWM
Curry Webb Wealth Management Indianapolis, Indiana $241M AUM
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
TP
Thayer Partners Wyndmoor, Pennsylvania $242M AUM
RA
Riverstone Advisors New Braunfels, Texas $241M AUM 38.63% 1-Year Est. Return
FA
Financial Avengers Oakland, California $241M AUM 23.49% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return

Alethea Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Alethea Capital Management held 72 positions worth $93.5M, down 1.3% from $94.7M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Alethea Capital Management withdrew a net $5.31M in Q2 2023, closing 21 positions and reducing 14 holdings. Its most notable exit was Fastenal, an estimated $735K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 77% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, Alethea Capital Management opened a new position in Exelon worth $611K.

  • Alethea Capital Management's largest Q2 2023 buy was Exelon: 14,988 shares worth $611K.
  • Alethea Capital Management added most to Pfizer in Q2 2023, an estimated $578K increase.
  • Alethea Capital Management's biggest Q2 2023 reduction was Axsome Therapeutics, cutting an estimated $1.9M.
  • Alethea Capital Management fully exited Fastenal in Q2 2023, selling an estimated $735K.
  • Alethea Capital Management's ten largest holdings make up 81% of its $93.5M portfolio in Q2 2023.
  • Alethea Capital Management opened 14 new positions and closed 21 in Q2 2023.
  • Alethea Capital Management's portfolio value fell 1.3% quarter-over-quarter to $93.5M.

Based on Alethea Capital Management's 13F filing for Q2 2023, filed 15 Aug 2023.